enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Why Is Regeneron Pharmaceuticals Stock Trading Lower Today? - AOL

    www.aol.com/why-regeneron-pharmaceuticals-stock...

    On Thursday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported third-quarter adjusted EPS of $12.46, up 8% year-over-year, beating the consensus of $11.69. The company reported sales of $3.72 ...

  3. What's Going On With Regeneron Pharmaceuticals Stock On ... - AOL

    www.aol.com/finance/whats-going-regeneron...

    On Friday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion recommending ...

  4. Regeneron preliminary Q4 US sales of Eylea below expectations

    www.aol.com/news/regeneron-preliminary-q4-us...

    Shares of Regeneron were down over 2% in premarket trading. Eylea, jointly developed with Bayer AG, has driven Regeneron's earnings for years, but sales have now come under pressure, partly from ...

  5. Regeneron stock surges on positive results in eye disease ...

    www.aol.com/news/regeneron-stock-surges-positive...

    Regeneron stock surges on positive results in eye disease drug trial. September 8, 2022 at 12:57 PM ...

  6. Regeneron (REGN) Earnings Expected to Grow: What to ... - AOL

    www.aol.com/news/regeneron-regn-earnings...

    For premium support please call: 800-290-4726 more ways to reach us

  7. Is Regeneron Pharmaceuticals Inc (REGN) A Good Stock To Buy?

    www.aol.com/news/regeneron-pharmaceuticals-inc...

    For premium support please call: 800-290-4726 more ways to reach us

  8. Why Regeneron Pharmaceuticals (REGN) Isn't Done Growing ... - AOL

    www.aol.com/news/why-regeneron-pharmaceuticals...

    For premium support please call: 800-290-4726 more ways to reach us

  9. Pharma giant Regeneron is spending $119.5M on the world ... - AOL

    www.aol.com/finance/pharma-giant-regeneron...

    Regeneron invested $119.5 million in Truveta’s Series C funding round, while Illumina chipped in $20 million. In addition, 17 of Truveta’s 30 partner health systems collectively contributed ...